Skip to content

Cinnamaldehyde Mucoadhesive Patches

Evaluation of Efficacy of Cinnamaldehyde Mucoadhesive Patches on Recurrent Aphthous Stomatitis: A Randomized Controlled Double Blind Clinical Trial. - NILL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/063126
Enrollment
51
Registered
2024-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K120- Recurrent oral aphthae

Interventions

Intervention1: Mucoadhesive Patches: Mucoadhesive Patches with Cinnamaldehyde in 5% and 10% concentrations in RAS patients for 7 days. Control Intervention1: Mucoadhesive Patches: Placebo mucoadhesive

Sponsors

VSPM DC RC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients clinically diagnosed with RAS will be selected based on case history and clinical examination. Patients above 18 years of age. Patients who are willing to participate in the study.

Exclusion criteria

Exclusion criteria: • Patients with any oral or systemic diseases. • Patients with herpetiform ulcers. • Patients on any medications. • Patients with habit of smoking. • Pregnant and lactating women. • History of hypersensitivity to cinnamon/cassia.

Design outcomes

Primary

MeasureTime frame
1. To evaluate efficacy of cinnamaldehyde on pain intensity with VAS score. 2. To evaluate efficacy of cinnamaldehyde for reduction in size of ulcer. 3. To evaluate and compare efficacy of cinnamaldehyde in different concentrations (5% and 10%).Timepoint: At 0 ,3rd and 7th day

Secondary

MeasureTime frame
SECONDARY OBJECTIVES 1. To evaluate Hematological parameters of patients with RAS. 2. To correlate stress with incidence of RAS with the help of Questionnaire.Timepoint: 7DAYS

Countries

India

Contacts

Public ContactDr Bushra Siddiquee

VSPM, DC, RC, Nagpur

motwanimukta@yahoo.co.in9372306210

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026